Through rigorous assessment and prioritization, Bayer is advancing key programs with significant potential. (Image Credits: Pixabay) Bayer on Tuesday announced that it was preparing market ...
Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...
Bayer's move leaves Merck still out in front – with an approval for gefapixant for cough in Japan where the drug is known as Lyfnua – but clearly casts a shadow on the class as a whole.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Forbes contributors publish independent expert analyses and insights. I write about the German football with a focus on the Bundesliga.
Barcelona facing unexpected competition from Bayer Leverkusen for 26-year-old sought-after full-back
According to Cule Mania, Barcelona’s efforts to secure Andrei Ratiu have hit a significant roadblock as Bayer Leverkusen have entered the race to sign the 26-year-old Romanian right-back. The defender ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results